Cargando…
Use of urinary naloxone levels in a single provider practice: a case study
BACKGROUND: Urine drug monitoring for medications for opioid use disorder (MOUD) such as buprenorphine can help to support treatment adherence. The practice of introducing unconsumed medication directly into urine (known as “spiking” samples) has been increasingly recognized as a potential means to...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6964102/ https://www.ncbi.nlm.nih.gov/pubmed/31941557 http://dx.doi.org/10.1186/s13722-020-0178-9 |